Amedica Launches New Lumbar Spinal Fusion Device

Amedica Corp., rolled out its latest anterior lumbar (AL) interbody fusion device made with the company’s proprietary silicon nitride material. According to the company, the Valeo II AL interbody fusion device includes “enhancements that contribute to improved surgeon ease of use and quality patient care.”

The Valeo II AL provides a new design that offers enhanced bone-to-implant interface and resistance to push out when compared to competitive offerings. The Valeo II AL is made out of Amedica’s Silicon Nitride biomaterial, which has been shown to help promote bone growth and also has anti-infective properties, the company claims. In addition, Valeo II AL silicon nitride interbody fusion devices are semi-radiolucent with clearly visible boundaries in X-rays and produce no artifacts under MRI or CT.

Amedica officials say that the combination of these properties is only found in its Silicon Nitride biomaterial technology.

“Amedica is committed to delivering products that address the changing needs of spinal surgeons.Our next generation silicon nitride AL device provides an optimal environment for bone growth while reducing the risk for infection due to its innate anti-infective properties. These benefits have the potential to improve the efficacyof spinal fusion procedures resulting in enhanced patient care,” said Eric Olson, president and CEO of Amedica. “As Amedica continues to collaborate with surgeons to develop innovative, safe and effective interbody fusion devices, silicon nitride is increasingly becoming the gold standard material for spinal fusion devices. With the launch of Valeo II AL, Amedica is positioned to rapidly increase our market share in the $1.6 billion interbody fusion device market.”

The Valeo II AL is indicated for intervertebral body fusion of the spine in skeletally mature patients and is designed for use with autograft to facilitate fusion.

Amedica is a privately owned company founded in 1996 in SaltLake City, Utah.